BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32066565)

  • 1. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
    Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
    Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
    Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
    J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.
    Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F
    Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail.
    Zhai S; Liu C; Zhang L; Zhu J; Guo J; Zhang J; Chen Z; Zhou W; Chang T; Xu S; Qi Y; Zhuang T; Yu N; Wang W; Wang H; Yu S; Li X
    Neoplasia; 2017 Mar; 19(3):154-164. PubMed ID: 28147304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 9. PLCE1 suppresses p53 expression in esophageal cancer cells.
    Li Y; An J; Huang S; Liao H; Weng Y; Cai S; Zhang J
    Cancer Invest; 2014 Jul; 32(6):236-40. PubMed ID: 24766303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer.
    Shi Q; Xu G; Jiang Y; Yang J; Han X; Wang Q; Li Y; Zhang Z; Wang K; Peng H; Chen F; Ma Y; Zhao L; Chen Y; Liu Z; Yang L; Jia X; Wen T; Tong Z; Cui X; Li F
    Cancer Res; 2024 Feb; 84(4):560-576. PubMed ID: 38117512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma.
    Wang H; Song X; Wang Y; Yin X; Liang Y; Zhang T; Xu L; Jiang F; Dong G
    Cell Death Dis; 2020 Nov; 11(11):1010. PubMed ID: 33239613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma.
    Yang Z; Hui Y; Peng H; Zhang H; Li M; Song L; Li F; Cui X
    Oncol Rep; 2021 Mar; 45(3):857-868. PubMed ID: 33650665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
    Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
    APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
    Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
    Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of PLCE1 intronic insertion variant associated with susceptibility to esophageal squamous cell carcinoma.
    Wei L; Shao M; Zhao Y; Zheng J; Chu J; Chang J; Cheng X; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Carcinogenesis; 2018 Feb; 39(2):191-201. PubMed ID: 29106514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.
    Wang YL; Yuan Y; Luo XX; Hu GY; Gong P
    Curr Med Sci; 2019 Jun; 39(3):385-390. PubMed ID: 31209807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.